Integrated bioinformatics analysis of miRNA expression in osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA (miRNA) dysregulation is implicated in osteosarcoma (OS) pathogenesis.
• Previous miRNA expression analyses in OS exhibit significant variability due to diverse sample selection and sequencing platforms.
• A need exists for reliable biomarkers for OS prognosis and treatment.

Purpose of the Study:

• To systematically analyze miRNA expression datasets to identify robust prognostic and therapeutic biomarkers for osteosarcoma.
• To overcome data heterogeneity in existing miRNA expression studies for OS.

Main Methods:

• Systematic selection and analysis of seven miRNA expression datasets from published osteosarcoma studies.
• Bioinformatic analysis to identify consistently dysregulated miRNAs and associated factors.

Main Results:

• Identification of two specific miRNAs, hsa-miR-19-3p and hsa-miR106b-3p, as potential biomarkers.
• Identification of the transcription factor SIX3 as a potential biomarker.
• These identified markers demonstrate potential for predicting prognosis and guiding treatment in osteosarcoma.

Conclusions:

• Hsa-miR-19-3p, hsa-miR106b-3p, and SIX3 are proposed as reliable biomarkers for osteosarcoma.
• These biomarkers may significantly aid in the prognostic assessment and therapeutic strategy development for osteosarcoma patients.
• Further validation is warranted to confirm their clinical utility.